Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp212 | Gestational and Type 1 Diabetes | ECE2019

Prevalence of gestational diabetes during 14 pregnancies of acromegalic women

Vialon Magaly , Grunenwald Solange , Mouly Celine , Vezzosi Delphine , Bennet Antoine , Caron Philippe

Introduction: Abnormalities of glycoregulation are frequent in acromegaly (15-38%) secondary to insulin resistance related to GH/IGF-1 hyper-secretion. The frequency of gestational diabetes (GD) in women with acromegaly was reported in the French multicenter study (JCEM, 2010, 95, 4680) as increased mainly in the absence of pre-gestational control of GH/IGF-1 hyper-secretion. The aim of this study was to evaluate the frequency of GD in a cohort of acromegalic women, and compar...

ea0081p159 | Pituitary and Neuroendocrinology | ECE2022

What is the relevance of he systematic use of gadolinium (Gd) during the MRI follow-up of non-functioning pituitary adenomas (NFPAs)?

Villemaire Axel , Mouly Celine , Solange Grunenwald , Adam Gilles , Darcourt Jean , Patsoura Sofia , Roques Margaux , Catalaa Isabelle , Fayolle Helio , Cognard Christophe , Sol Jean-Christophe , Caron Philippe , Fabrice Bonneville

Objective: To compare the performances of the coronal contrast-enhanced T1-weighted (ceT1-w) and T2-weighted (T2-w) sequences, for the diagnosis of progression during the MRI follow-up of NFPAs.Materials and methods: 106 patients who had at least two MRIs for the follow-up of NFPA were retrospectively included. The largest diameter of the adenomas was measured on coronal ceT1-w and separately on T2-w sequences for all the MRIs of the follow-up, and by 2 ...

ea0099oc5.5 | Oral Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

B-RAF and MEK inhibitor argeted therapy in papillary craniopharyngiomas: results from the French national multicenter study

De Alcubierre Dario , Gkasdaris Grigorios , Briet Claire , Almairac Fabien , Boetto Julien , Mouly Celine , Larrieu-Ciron Delphine , Joncour Anthony , Mordrel Margaux , Vasiljevic Alexandre , Villa Chiara , Sergeant Camille , Ducray Francois , Feuvret Loic , Baussart Bertrand , Raverot Gerald , Jouanneau Emmanuel

Background: Papillary craniopharyngiomas (PCPs) are driven by V600E BRAF mutations in 95% of cases. Recently, combined anti-BRAF/MEK targeted therapy (TT) has emerged as a potential treatment in aggressive PCPs. However, standardized data on large cohorts are still lacking. Our study aimed to assess the real-life efficacy and safety of TT in patients with PCPs.Methods: This was a retrospective national multicenter study involving patients with V600E BRAF...